carbamates has been researched along with Anxiety in 68 studies
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We showed that JZL184 reduced both the cue- and stress-induced reinstatement of methamphetamine-seeking and anxiety-like behaviors in rats that had self-administered methamphetamine." | 7.91 | Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats. ( Fukumori, R; Nawata, Y; Yamaguchi, T; Yamamoto, T, 2019) |
| " In Wistar rats, URB597 effects on alcohol-induced anxiety and on stress-, yohimbine- and cue-induced reinstatement of alcohol seeking were also evaluated." | 7.74 | Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. ( Bilbao, A; Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Defonseca, FR; Duranti, A; Piomelli, D; Tontini, A, 2008) |
| "Our results reveal that experimentally increasing anandamide levels in female prairie voles can increase social contact with both a familiar and novel male via unknown mechanisms that are likely separate from anxiety reduction." | 4.02 | Effects of systemic endocannabinoid manipulation on social and exploratory behavior in prairie voles (Microtus ochrogaster). ( Bales, KL; Simmons, TC; Singh, ALK, 2021) |
| "This study was designed to determine the involvement of the endocannabinoid system in anxiety- and depression-related behaviors in methamphetamine-withdrawal male NMRI mice." | 4.02 | URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels. ( Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR, 2021) |
| "We showed that JZL184 reduced both the cue- and stress-induced reinstatement of methamphetamine-seeking and anxiety-like behaviors in rats that had self-administered methamphetamine." | 3.91 | Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats. ( Fukumori, R; Nawata, Y; Yamaguchi, T; Yamamoto, T, 2019) |
| " Exposure to phenobarbital during this period has been associated with deficits in learning and memory, anxiety-like behavior, and social behavior, among other domains." | 3.83 | Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats. ( Forcelli, PA; Frankel, S; Gutherz, S; Kondratyev, A; Kulick, C; Medvedeva, N, 2016) |
| " Here, we investigated whether prenatal stress--in the form of gestational exposure to corticosterone supplemented in the maternal drinking water (100 mg/l) during the last week of pregnancy--combined with a pharmacological stimulation of the ECS during adolescence (daily fatty acid amide hydrolase URB597 i." | 3.78 | Prenatal stress and peripubertal stimulation of the endocannabinoid system differentially regulate emotional responses and brain metabolism in mice. ( Canese, R; Ceci, C; Laviola, G; Macrì, S, 2012) |
| "In the present study we explored with a multidisciplinary approach, the role of anandamide (AEA) in the modulation of anxiety behavior at the level of the prefrontal cortex (PFC)." | 3.74 | Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. ( Castiglioni, C; Di Marzo, V; Guidali, C; Maccarrone, M; Marras, E; Parolaro, D; Perletti, G; Petrosino, S; Realini, N; Rubino, T; Viganó, D, 2008) |
| " In Wistar rats, URB597 effects on alcohol-induced anxiety and on stress-, yohimbine- and cue-induced reinstatement of alcohol seeking were also evaluated." | 3.74 | Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. ( Bilbao, A; Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Defonseca, FR; Duranti, A; Piomelli, D; Tontini, A, 2008) |
| "We hypothesized that restless legs syndrome (RLS), a common neurological sensorimotor disorder of uncomfortable leg sensations that appear at night and interfere with sleep, might be a cause for nighttime agitation in persons with AD." | 2.94 | Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest). ( Allen, R; Fry, L; Gooneratne, N; Hanlon, A; Kovach, C; Loera, A; Lozano, A; Morrison, J; Rangel, A; Richards, K; Wang, YY, 2020) |
| "Similar to clinical PTSD, approximately 25-30% of rats that undergo cued fear conditioning exhibit impaired extinction learning." | 1.56 | Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. ( Diwan, M; Giacobbe, P; Gidyk, DC; Gouveia, FV; Hamani, C; Lipsman, N; Nobrega, JN; Vimalanathan, A, 2020) |
| "Treatment with diazepam (1 mg/kg) increased tolerance without affecting avoidance behavior in HAB mice." | 1.46 | Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle. ( Genewsky, A; Heinz, DE; Wotjak, CT, 2017) |
| "Remarkably, the long-lasting widespread hyperalgesia induced by combining CUS and NGF was effectively reduced by URB597, but not by JZL184." | 1.42 | Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. ( Bindila, L; Hoheisel, U; Lerner, R; Lomazzo, E; Lutz, B; Remmers, F; Schwitter, C, 2015) |
| "Status epilepticus was induced by administration of KA either intraperitoneally (15 mg/kg) or by single intrahippocampal injection (1." | 1.40 | Retigabine calms seizure-induced behavior following status epilepticus. ( Ali, SS; Friedman, LK; Naseer, Z; Slomko, AM; Wongvravit, JP, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (41.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (17.65) | 29.6817 |
| 2010's | 22 (32.35) | 24.3611 |
| 2020's | 6 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| da Motta, KP | 1 |
| Santos, BF | 1 |
| Domingues, NLC | 1 |
| Luchese, C | 1 |
| Wilhelm, EA | 1 |
| Vimalanathan, A | 1 |
| Gidyk, DC | 1 |
| Diwan, M | 1 |
| Gouveia, FV | 1 |
| Lipsman, N | 1 |
| Giacobbe, P | 1 |
| Nobrega, JN | 1 |
| Hamani, C | 1 |
| Ferizovic, H | 1 |
| Spasojevic, N | 1 |
| Stefanovic, B | 1 |
| Jankovic, M | 1 |
| Dronjak, S | 1 |
| Richards, K | 1 |
| Morrison, J | 1 |
| Wang, YY | 1 |
| Rangel, A | 1 |
| Loera, A | 1 |
| Hanlon, A | 1 |
| Lozano, A | 1 |
| Kovach, C | 1 |
| Gooneratne, N | 1 |
| Fry, L | 1 |
| Allen, R | 1 |
| Simmons, TC | 1 |
| Singh, ALK | 1 |
| Bales, KL | 1 |
| Ebrahimi-Ghiri, M | 1 |
| Khakpai, F | 1 |
| Zarrindast, MR | 1 |
| Aisenberg, N | 1 |
| Serova, L | 1 |
| Sabban, EL | 1 |
| Akirav, I | 1 |
| Seillier, A | 2 |
| Giuffrida, A | 2 |
| Heinz, DE | 1 |
| Genewsky, A | 1 |
| Wotjak, CT | 1 |
| Flannery, LE | 1 |
| Kerr, DM | 1 |
| Finn, DP | 1 |
| Roche, M | 1 |
| Nawata, Y | 1 |
| Yamaguchi, T | 1 |
| Fukumori, R | 1 |
| Yamamoto, T | 1 |
| Hartmann, A | 1 |
| Fassini, A | 2 |
| Scopinho, A | 1 |
| Correa, FM | 1 |
| Guimarães, FS | 2 |
| Lisboa, SF | 2 |
| Resstel, LB | 3 |
| Banji, D | 1 |
| Banji, OJ | 1 |
| Ragini, M | 1 |
| Annamalai, AR | 1 |
| Slomko, AM | 1 |
| Naseer, Z | 1 |
| Ali, SS | 1 |
| Wongvravit, JP | 1 |
| Friedman, LK | 1 |
| Lomazzo, E | 1 |
| Bindila, L | 1 |
| Remmers, F | 1 |
| Lerner, R | 1 |
| Schwitter, C | 1 |
| Hoheisel, U | 1 |
| Lutz, B | 2 |
| Viana, TG | 1 |
| Hott, SC | 1 |
| Aguiar, DC | 1 |
| Moreira, FA | 2 |
| Borges, AA | 1 |
| Nejo, P | 1 |
| Manduca, A | 1 |
| Morena, M | 2 |
| Campolongo, P | 2 |
| Servadio, M | 1 |
| Palmery, M | 1 |
| Trabace, L | 1 |
| Hill, MN | 2 |
| Vanderschuren, LJ | 1 |
| Cuomo, V | 1 |
| Trezza, V | 1 |
| Qin, M | 1 |
| Zeidler, Z | 1 |
| Moulton, K | 1 |
| Krych, L | 1 |
| Xia, Z | 1 |
| Smith, CB | 1 |
| Carnevali, L | 1 |
| Vacondio, F | 1 |
| Rossi, S | 1 |
| Macchi, E | 1 |
| Spadoni, G | 1 |
| Bedini, A | 1 |
| Neumann, ID | 1 |
| Rivara, S | 1 |
| Mor, M | 2 |
| Sgoifo, A | 1 |
| Aliczki, M | 1 |
| Barna, I | 2 |
| Till, I | 1 |
| Baranyi, M | 1 |
| Sperlagh, B | 1 |
| Goldberg, SR | 2 |
| Haller, J | 3 |
| Frankel, S | 1 |
| Medvedeva, N | 1 |
| Gutherz, S | 1 |
| Kulick, C | 1 |
| Kondratyev, A | 1 |
| Forcelli, PA | 1 |
| Leitl, KD | 1 |
| Vecchiarelli, HA | 1 |
| Gray, JM | 1 |
| Micale, V | 1 |
| Cristino, L | 1 |
| Tamburella, A | 1 |
| Petrosino, S | 2 |
| Leggio, GM | 1 |
| Drago, F | 1 |
| Di Marzo, V | 2 |
| Barsvari, B | 1 |
| Gyimesi Pelczer, K | 1 |
| Yasar, S | 2 |
| Panlilio, LV | 1 |
| Goldberg, S | 1 |
| Roohbakhsh, A | 1 |
| Keshavarz, S | 1 |
| Hasanein, P | 1 |
| Rezvani, ME | 1 |
| Moghaddam, AH | 1 |
| Cippitelli, A | 2 |
| Astarita, G | 1 |
| Duranti, A | 3 |
| Caprioli, G | 1 |
| Ubaldi, M | 1 |
| Stopponi, S | 1 |
| Kallupi, M | 1 |
| Sagratini, G | 1 |
| Rodrìguez de Fonseca, F | 1 |
| Piomelli, D | 4 |
| Ciccocioppo, R | 2 |
| Zaitone, SA | 1 |
| El-Wakeil, AF | 1 |
| Abou-El-Ela, SH | 1 |
| Macrì, S | 1 |
| Ceci, C | 1 |
| Canese, R | 1 |
| Laviola, G | 1 |
| Khatri, M | 1 |
| Rai, SK | 1 |
| Ranbhor, R | 1 |
| Kishore, K | 1 |
| Tiwari, M | 1 |
| HALPERN, BN | 1 |
| LEHMANN, A | 1 |
| GILLHESPY, RO | 1 |
| CAHN, B | 1 |
| DARBELLAY, J | 1 |
| HSU, JJ | 1 |
| BRAUN, RA | 1 |
| DOMINO, EF | 1 |
| LOWINGER, P | 1 |
| SCHORER, C | 1 |
| BRUCK, M | 1 |
| CAUSSE, R | 1 |
| TOFFOL, DE | 1 |
| D AMELIO, V | 1 |
| ANNOVI, G | 1 |
| RAAB, E | 1 |
| RICKELS, K | 1 |
| MOORE, E | 1 |
| GREENWALD, AS | 1 |
| SEEHERMAN, R | 1 |
| GANTT, WH | 1 |
| BUTTON, JT | 1 |
| COLE, WV | 1 |
| CHESROW, EJ | 1 |
| KAPLITZ, SE | 1 |
| SABATINI, R | 1 |
| VETRA, H | 1 |
| MARQUARDT, GH | 1 |
| Korsgaard, MP | 1 |
| Hartz, BP | 1 |
| Brown, WD | 1 |
| Ahring, PK | 1 |
| Strøbaek, D | 1 |
| Mirza, NR | 2 |
| Blackburn-Munro, G | 1 |
| Dalby-Brown, W | 1 |
| Mikkelsen, JD | 1 |
| Blackburn-Munro, RE | 1 |
| Tarzia, G | 1 |
| Tontini, A | 2 |
| Compton, TR | 1 |
| Dasse, O | 1 |
| Monaghan, EP | 1 |
| Parrott, JA | 1 |
| Putman, D | 1 |
| Naidu, PS | 1 |
| Varvel, SA | 1 |
| Ahn, K | 1 |
| Cravatt, BF | 1 |
| Martin, BR | 1 |
| Lichtman, AH | 1 |
| Kaiser, N | 1 |
| Monory, K | 1 |
| Scherma, M | 1 |
| Medalie, J | 1 |
| Fratta, W | 1 |
| Vadivel, SK | 1 |
| Makriyannis, A | 1 |
| Mikics, E | 1 |
| Tanda, G | 1 |
| Rubino, T | 1 |
| Realini, N | 1 |
| Castiglioni, C | 1 |
| Guidali, C | 1 |
| Viganó, D | 1 |
| Marras, E | 1 |
| Perletti, G | 1 |
| Maccarrone, M | 1 |
| Parolaro, D | 1 |
| Naderi, N | 1 |
| Haghparast, A | 1 |
| Saber-Tehrani, A | 1 |
| Rezaii, N | 1 |
| Alizadeh, AM | 1 |
| Khani, A | 1 |
| Motamedi, F | 1 |
| Cannella, N | 1 |
| Braconi, S | 1 |
| Bilbao, A | 1 |
| Defonseca, FR | 1 |
| Spry, WB | 1 |
| Linford Rees, W | 1 |
| Guthy, H | 1 |
| Kissin, B | 1 |
| Gross, MM | 1 |
| DiMascio, A | 2 |
| Gardos, G | 1 |
| Harmatz, J | 1 |
| Shader, R | 1 |
| Shader, RI | 1 |
| Harmatz, JS | 1 |
| Lehmann, HE | 1 |
| Ban, TA | 1 |
| Bratfos, O | 1 |
| Lingjaerde, O | 1 |
| Salvesen, C | 1 |
| Cremoncini, C | 1 |
| Liuzzi, A | 1 |
| Perez de Francisco, C | 1 |
| Meshel, E | 1 |
| Denber, HC | 1 |
| Solaro, F | 1 |
| Corletto, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease[NCT03082755] | Phase 4 | 156 participants (Anticipated) | Interventional | 2017-07-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for carbamates and Anxiety
| Article | Year |
|---|---|
Retigabine: chemical synthesis to clinical application.
Topics: Animals; Anticonvulsants; Anxiety; Carbamates; Dose-Response Relationship, Drug; Epilepsy; Humans; K | 2005 |
Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).
Topics: Amidohydrolases; Analgesics; Animals; Anxiety; Benzamides; Brain; Cannabinoids; Carbamates; Depressi | 2006 |
Pharmacotherapy of tension and anxiety.
Topics: Anxiety; Automobile Driving; Carbamates; Cerebral Cortex; Clinical Trials as Topic; Depression; Dibe | 1972 |
7 trials available for carbamates and Anxiety
| Article | Year |
|---|---|
Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest).
Topics: Aged; Alzheimer Disease; Anxiety; Carbamates; Double-Blind Method; Female; gamma-Aminobutyric Acid; | 2020 |
Tybamate: an examination of its actions in "high" and "low" anxious normals.
Topics: Adult; Anxiety; Blood Pressure; Carbamates; Chlordiazepoxide; Clinical Trials as Topic; Cognition; E | 1969 |
Single versus repeated dosage of the minor tranquilizer chlordiazepoxide (Librium).
Topics: Adult; Anxiety; Blood Pressure; Carbamates; Chlordiazepoxide; Clinical Trials as Topic; Evaluation S | 1972 |
Pharmacotherapy of tension and anxiety.
Topics: Anxiety; Automobile Driving; Carbamates; Cerebral Cortex; Clinical Trials as Topic; Depression; Dibe | 1972 |
Symptomatic relief of neurotic symptoms with tybamate: a doube-blind, placebo-controlled study.
Topics: Adult; Aged; Anxiety; Carbamates; Clinical Trials as Topic; Depression; Female; Humans; Hysteria; Ma | 1967 |
Serax and solacen.
Topics: Aged; Antidepressive Agents; Anxiety; Carbamates; Clinical Trials as Topic; Humans; Hyperventilation | 1965 |
Double-blind study of tybamate in psychotic patients.
Topics: Adult; Aged; Aggression; Anxiety; Carbamates; Clinical Trials as Topic; Depression; Female; Humans; | 1967 |
59 other studies available for carbamates and Anxiety
| Article | Year |
|---|---|
Target enzymes in oxaliplatin-induced peripheral neuropathy in Swiss mice: A new acetylcholinesterase inhibitor as therapeutic strategy.
Topics: Adenosine Triphosphatases; Analgesics; Animals; Anxiety; Benzoates; Carbamates; Cerebral Cortex; Cho | 2022 |
Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
Topics: Animals; Anxiety; Benzamides; Benzoxazines; Carbamates; Conditioning, Psychological; Disease Models, | 2020 |
The fatty acid amide hydrolase inhibitor URB597 modulates splenic catecholamines in chronically stressed female and male rats.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Benzamides; Carbamates; Catechol O-Methyltra | 2020 |
Effects of systemic endocannabinoid manipulation on social and exploratory behavior in prairie voles (Microtus ochrogaster).
Topics: Animals; Anxiety; Arachidonic Acids; Arvicolinae; Behavior, Animal; Benzamides; Carbamates; Endocann | 2021 |
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
Topics: Amidohydrolases; Animals; Anxiety; Behavior, Animal; Benzamides; Cannabinoid Receptor Antagonists; C | 2021 |
The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event.
Topics: Amidohydrolases; Animals; Anxiety; Basolateral Nuclear Complex; Benzamides; CA1 Region, Hippocampal; | 2017 |
Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Cannabinoids; Carbamates | 2017 |
Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Avoidance Learning; Behav | 2017 |
FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats.
Topics: Amidohydrolases; Animals; Anxiety; Benzamides; Carbamates; Central Nervous System Agents; Enzyme Inh | 2018 |
Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
Topics: Amidohydrolases; Amphetamine-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Add | 2019 |
Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Arterial Pressure; Behavior, Animal; Benzamide | 2019 |
Carbosulfan exposure during embryonic period can cause developmental disability in rats.
Topics: Acetylcholinesterase; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Brain; Carbamates; Embry | 2014 |
Retigabine calms seizure-induced behavior following status epilepticus.
Topics: Animals; Anticonvulsants; Anxiety; Behavior, Animal; Carbamates; Convulsants; Hippocampus; Hyperkine | 2014 |
Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain.
Topics: Amidohydrolases; Analgesics, Non-Narcotic; Animals; Anxiety; Benzamides; Benzodioxoles; Brain; Carba | 2015 |
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Carbamates; Dise | 2015 |
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence.
Topics: Animals; Anxiety; Arachidonic Acids; Benzamides; Carbamates; Disease Models, Animal; Drinking; Drink | 2015 |
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
Topics: Aging; Animals; Anxiety; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Carbamates; Endo | 2015 |
Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Avoidance Learning; Benzamides; Cannabinoid Re | 2015 |
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arrhythmias, Cardiac; Behavior, Animal; Biph | 2015 |
The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats.
Topics: Adaptation, Psychological; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Basolateral Nuc | 2016 |
Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats.
Topics: Animals; Animals, Newborn; Anticonvulsants; Anxiety; Behavior, Animal; Carbamates; Cognition; Dose-R | 2016 |
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety.
Topics: Animals; Anxiety; Arachidonic Acids; Arousal; Basolateral Nuclear Complex; Benzamides; Cannabinoid R | 2016 |
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Topics: Amidohydrolases; Anilides; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzamides; Bra | 2009 |
Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Benzamides; Carbamates; Chlordiazepoxide; Di | 2009 |
Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
Topics: Amidohydrolases; Animals; Anxiety; Baclofen; Behavior, Animal; Benzamides; Bicuculline; Cannabinoid | 2009 |
Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzamides; Carbamates; En | 2011 |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.
Topics: Acute Disease; Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Benzamides; Brain; Cannabinoid | 2011 |
Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
Topics: Acetaminophen; Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzamides | 2012 |
Prenatal stress and peripubertal stimulation of the endocannabinoid system differentially regulate emotional responses and brain metabolism in mice.
Topics: Anhedonia; Animals; Anxiety; Benzamides; Body Weight; Brain; Carbamates; Corticosterone; Drinking; E | 2012 |
Synthesis and pharmacological evaluation of [(4-arylpiperazin-1-yl)-alkyl]-carbamic acid ethyl ester derivatives as potential anxiolytic agents.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Carbamates; Cerebral Cortex; Computer-Aided | 2012 |
[Experimental bases of the therapeutic action of a new sedative and anti-anxious preparation: 3-methyl-1-pentyne-3-o1 carbamate].
Topics: Anxiety; Carbamates; Humans; Hypnotics and Sedatives; Tranquilizing Agents | 1957 |
Methylpentynol carbamate in the management of insomnia and parkinsonism.
Topics: Anxiety; Carbamates; Humans; Parkinson Disease; Parkinsonian Disorders; Sleep Initiation and Mainten | 1958 |
Effect of hydroxyphenamate in the treatment of mild and moderate anxiety states. (A double blind study with crossover pattern).
Topics: Anxiety; Butylene Glycols; Carbamates; Double-Blind Method; Tranquilizing Agents | 1961 |
[THE ORTHONEUROTIC EMYLCAMATE IN DAILY PRACTICE].
Topics: Alcoholism; Anxiety; Anxiety Disorders; Automobiles; Carbamates; Cats; Depression; Geriatrics; Mice; | 1963 |
CLINICAL EVALUATION OF HYDROXYPHENAMATE IN PSYCHOTIC PATIENTS.
Topics: Anxiety; Brain; Brain Damage, Chronic; Butylene Glycols; Carbamates; Humans; Mental Disorders; Psych | 1963 |
[VALUE OF 1-CYCLOHEXYLPROPYL CARBAMATE IN NEURO-PSYCHIATRY].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Carbamates; Humans; Neurolog | 1963 |
[TREATMENT WITH MEBUTAMATE (AN ANTIHYPERTENSIVE WITH CENTRAL ACTION) OF MENTAL PATIENTS WITH HYPERTENSIVE MANIFESTATIONS].
Topics: Alcoholism; Antihypertensive Agents; Anxiety; Bipolar Disorder; Carbamates; Dementia; Epilepsy; Huma | 1963 |
A DOUBLE-BLIND EVALUATION OF TYBAMATE IN ANXIOUS NEUROTIC MEDICAL CLINIC PATIENTS.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Black People; Carbamates; Double-Blind Method; Huma | 1964 |
RELIEF OF TENSION IN DENTAL PATIENTS: A CONTROLLED STUDY WITH HYDROXYPHENAMATE.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Butylene Glycols; Carbamates; Dentistry; Pharmacolo | 1964 |
EVALUATION OF TYBAMATE IN THE CLINICAL MANAGEMENT OF ANXIETY.
Topics: Anxiety; Biomedical Research; Carbamates; Placebos; Toxicology; Tranquilizing Agents | 1964 |
THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. EXPERIMENTAL STUDIES IN ANIMALS OF THE EFFECTS OF DRUGS ON CARDIAC STRESS SYMPTOMS.
Topics: Animals; Anxiety; Blood Pressure; Carbamates; Conditioning, Classical; Dogs; Electrocardiography; He | 1964 |
TREATMENT OF EMOTIONAL DISTURBANCES IN CLINIC PATIENTS.
Topics: Adolescent; Affective Symptoms; Anxiety; Anxiety Disorders; Biomedical Research; Carbamates; Drug Th | 1965 |
A NEW PSYCHOTHERAPEUTIC AGENT EFFECTIVE IN THE MANAGEMENT OF GERIATRIC ANXIETY, DEPRESSION AND BEHAVIORAL REACTIONS.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Brain; Brain Damage, Chronic; Carbamates; Depressio | 1965 |
Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
Topics: Algorithms; Animals; Anti-Anxiety Agents; Anxiety; Ataxia; Behavior, Animal; Carbamates; Cell Line; | 2005 |
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Cannabinoid Rece | 2007 |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Topics: Amidohydrolases; Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzam | 2008 |
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
Topics: Amidohydrolases; Analgesics; Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Avoidance Le | 2008 |
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.
Topics: Animals; Anxiety; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Dose-R | 2008 |
Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Benzoxazines; Ca | 2008 |
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
Topics: Adrenergic alpha-Antagonists; Alcohol Drinking; Alcoholism; Amidohydrolases; Animals; Anxiety; Arach | 2008 |
Tybamate.
Topics: Anxiety; Carbamates; Depression; Humans; Tranquilizing Agents | 1967 |
Tybamate: a new tranquillizer.
Topics: Adolescent; Adult; Anxiety; Carbamates; Depression; Female; Humans; Male; Middle Aged; Tranquilizing | 1967 |
The treatment of anxiety states by drugs and other means.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety; Barbit | 1979 |
[The medicinal treatment of anxiety in alcoholism in the withdrawal stage (author's transl)].
Topics: Adult; Alcoholism; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Carbamates; Chemical Phenomena; Ch | 1975 |
Drug therapy in alcoholism.
Topics: Adult; Alcoholic Intoxication; Alcoholism; Antidepressive Agents; Anxiety; Carbamates; Chlordiazepox | 1970 |
[Tybamate, recently synthetized anxiolytic agent, in the treatment of emotional and neurovegetative symptoms of hyperthyroidism. Clinico-statistical study].
Topics: Adolescent; Adult; Affective Symptoms; Aged; Animals; Anxiety; Autonomic Nervous System; Carbamates; | 1972 |
[Psychopharmacological treatment of anxiety].
Topics: Adult; Amitriptyline; Anxiety; Benzazepines; Carbamates; Chlordiazepoxide; Diazepam; Dibenzazepines; | 1971 |
[Tybamate in the practice at geriatric outpatient clinics].
Topics: Aged; Anxiety; Brain Damage, Chronic; Carbamates; Depression; Female; Humans; Male; Middle Aged; Out | 1968 |
Evaluation of a new minor tranquilizer: tybamate (Solacen).
Topics: Anxiety; Carbamates; Humans; Tranquilizing Agents | 1965 |